Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis.
Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial.
[Factors Influencing Lead Time in Multiple Sclerosis: Survey of Members of the German Multiple Sclerosis Society in Saxony-Anhalt].
Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis.
Vertebral hemangiomas in the thoracic spine of multiple sclerosis patients are connected with fewer demyelinating lesions at the same level. Possible impact on pathophysiology and clinical course.
Delayed iron deposit and atrophy of the putamen in a case with osmotic demyelination syndrome.
Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
Smoking increases the risk of progression in multiple sclerosis: A cohort study in Queensland, Australia.
Regulation of PERK-eIF2α signalling by tuberous sclerosis complex-1 controls homoeostasis and survival of myelinating oligodendrocytes.
Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab.
No evidence for increased brain iron deposition in patients with ischemic white matter disease.
Clinical Profiles and Short-Term Outcomes of Acute Disseminated Encephalomyelitis in Adult Chinese Patients.
Identification of gene expression patterns critically involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
Bladder function and falls in individuals with multiple sclerosis.
Interleukin 2 activates brain microvascular endothelial cells resulting in destabilization of adherens junctions.
Port-to-port delivery: Mobilization of toxic sphingolipids via extracellular vesicles.
Poster 362 Osmotic Demyelination in Lyme Disease: A Case Report.
Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis.
Engineering Biomaterials to Influence Oligodendroglial Growth, Maturation, and Myelin Production.
Response on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.
Developing connections amongst B lymphocytes and deregulated pathways in autoimmunity.
Interferon beta-1b-induced postmenopausal bleeding in a patient with multiple sclerosis.
Rabies virus-mediated oligodendrocyte labeling reveals a single oligodendrocyte myelinates axons from distinct brain regions.
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.

Pages